MDFZF Financials Monday, July 14, 2014 11:06:08 PM
Medifocus, Inc.
Period Ending Mar 31, 2013 Mar 31, 2012 Apr 01, 2011 Apr 01, 2010
Total Revenue 1,775 - - -
Cost of Revenue 968 - - -
Gross Profit 807 - - -
Operating Expenses
Research and Development 1,420 599 312 490
Sales, General and Admin. 4,801 795 1,384 566
Non-Recurring Items - - - -
Other 7 6 7 9
Operating Income (5,420) (1,400) (1,703) (1,065)
Income From Continuing Operations
Add'l Income/Expense Items (133) 39 67 235
Earnings Before Interest and Tax (5,553) (1,414) (1,636) (830)
Interest Expense 175 95 53 38
Earnings Before Tax (5,728) (1,509) (1,689) (868)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,728) (1,456) (1,689) (868)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,728) (1,456) (1,689) (868)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,728) (1,456) (1,689) (868)
Medifocus, Inc.
Period Ending Mar 31, 2013 Mar 31, 2012 Apr 01, 2011 Apr 01, 2010
Total Revenue 1,775 - - -
Cost of Revenue 968 - - -
Gross Profit 807 - - -
Operating Expenses
Research and Development 1,420 599 312 490
Sales, General and Admin. 4,801 795 1,384 566
Non-Recurring Items - - - -
Other 7 6 7 9
Operating Income (5,420) (1,400) (1,703) (1,065)
Income From Continuing Operations
Add'l Income/Expense Items (133) 39 67 235
Earnings Before Interest and Tax (5,553) (1,414) (1,636) (830)
Interest Expense 175 95 53 38
Earnings Before Tax (5,728) (1,509) (1,689) (868)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,728) (1,456) (1,689) (868)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,728) (1,456) (1,689) (868)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,728) (1,456) (1,689) (868)
